{"transactions":[{"id":747480,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-06-05T22:00:15.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":1690700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on June 3, 2027 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":1690700,"derivative":{"exercise_price":4.68,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":1690700},"source":{"system":"sec-edgar","filing":"0001610384-26-000002","document":"form4-06052026_060611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000161038426000002/form4-06052026_060611.xml","form_type":"4"}},{"id":959354,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-23T21:15:09.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":2250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on December 22, 2026 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":2250000,"derivative":{"exercise_price":3.98,"expiration_date":"2035-12-21","underlying":"Common Stock","underlying_shares":2250000},"source":{"system":"sec-edgar","filing":"0001610384-25-000005","document":"form4-12232025_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000161038425000005/form4-12232025_041201.xml","form_type":"4"}},{"id":1340128,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-12-06T22:45:05.000Z","date":"2024-12-05","kind":"grant","planned":false,"acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on December 5, 2025 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":105000,"derivative":{"exercise_price":2.12,"expiration_date":"2034-12-04","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001415889-24-028538","document":"form4-12062024_051201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000141588924028538/form4-12062024_051201.xml","form_type":"4"}},{"id":1764209,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-10-05T20:34:09.000Z","date":"2023-10-04","kind":"grant","planned":false,"acquired":true,"shares":100450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on October 4, 2024 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":100450,"derivative":{"exercise_price":6.41,"expiration_date":"2033-10-03","underlying":"Common Stock","underlying_shares":100450},"source":{"system":"sec-edgar","filing":"0001209191-23-052206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919123052206/doc4.xml","form_type":"4"}},{"id":1907884,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-05-02T22:15:06.000Z","date":"2023-05-02","kind":"sale","planned":false,"acquired":false,"shares":3641,"price":3.76,"value":13690.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of the PRSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.56 to $3.90 inclusive."}],"balance_after":68994,"source":{"system":"sec-edgar","filing":"0001209191-23-026683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919123026683/doc4.xml","form_type":"4"}},{"id":1907883,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-05-02T22:15:06.000Z","date":"2023-05-01","kind":"sale","planned":false,"acquired":false,"shares":23753,"price":3.85,"value":91449.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the settlement of the PRSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.52 to $4.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4)."}],"balance_after":72635,"source":{"system":"sec-edgar","filing":"0001209191-23-026683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919123026683/doc4.xml","form_type":"4"}},{"id":1907882,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-05-02T22:15:06.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":88077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon the vesting of performance-based restricted stock units (\"PRSUs\"), representing 50% of the shares underlying the PRSUs. On April 28, 2023, the Compensation Committee of the Board of Directors of the Issuer certified the achievement of a performance condition, which occurs upon FDA acceptance of a new drug application for roluperidone."}],"balance_after":96388,"source":{"system":"sec-edgar","filing":"0001209191-23-026683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919123026683/doc4.xml","form_type":"4"}},{"id":2086134,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-12-14T21:50:22.000Z","date":"2022-12-13","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on December 13, 2023 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":45000,"derivative":{"exercise_price":3.11,"expiration_date":"2032-12-12","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-22-061239","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919122061239/doc4.xml","form_type":"4"}},{"id":2384743,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-18T21:33:11.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":505000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on February 16, 2023 and then in equal quarterly installments over 3 years thereafter."}],"balance_after":505000,"derivative":{"exercise_price":0.791,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":505000},"source":{"system":"sec-edgar","filing":"0001209191-22-011299","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919122011299/doc4.xml","form_type":"4"}},{"id":2941865,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit","published_at":"2020-12-17T01:29:53.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001209191-20-063923","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120063923/doc4.xml","form_type":"4"}},{"id":2941864,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-12-17T01:29:53.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":1300,"price":2.64,"value":3432.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants."}],"balance_after":66490,"source":{"system":"sec-edgar","filing":"0001209191-20-063923","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120063923/doc4.xml","form_type":"4"}},{"id":2941863,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-12-17T01:29:53.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":18750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":67790,"source":{"system":"sec-edgar","filing":"0001209191-20-063923","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120063923/doc4.xml","form_type":"4"}},{"id":3006806,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-14T21:21:16.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of this option vests on December 31, 2021 and the balance vests on December 31, 2022."}],"balance_after":200000,"derivative":{"exercise_price":3.5,"expiration_date":"2030-10-12","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-20-054805","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120054805/doc4.xml","form_type":"4"}},{"id":3055481,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-08-17T20:28:02.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":354302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter."}],"balance_after":354302,"derivative":{"exercise_price":7.11,"expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":354302},"source":{"system":"sec-edgar","filing":"0001209191-20-046949","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120046949/doc4.xml","form_type":"4"}},{"id":3321426,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-03T21:48:34.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":95698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests 25% on December 31, 2019 and then in quarterly installments over 3 years thereafter."}],"balance_after":95698,"derivative":{"exercise_price":7.11,"expiration_date":"2029-12-30","underlying":"Common Stock","underlying_shares":95698},"source":{"system":"sec-edgar","filing":"0001209191-20-001107","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919120001107/doc4.xml","form_type":"4"}},{"id":3338208,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit","published_at":"2019-12-17T21:46:59.000Z","date":"2019-12-14","kind":"exercise","acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date."}],"balance_after":18750,"derivative":{"underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001209191-19-060887","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919119060887/doc4.xml","form_type":"4"}},{"id":3338207,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-12-17T21:46:59.000Z","date":"2019-12-17","kind":"sale","acquired":false,"shares":2412,"price":7.1,"value":17125.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants."}],"balance_after":49040,"source":{"system":"sec-edgar","filing":"0001209191-19-060887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919119060887/doc4.xml","form_type":"4"}},{"id":3338206,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-12-17T21:46:59.000Z","date":"2019-12-14","kind":"exercise","acquired":true,"shares":18750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":51452,"source":{"system":"sec-edgar","filing":"0001209191-19-060887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919119060887/doc4.xml","form_type":"4"}},{"id":3726205,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit","published_at":"2018-12-18T21:28:07.000Z","date":"2018-12-14","kind":"exercise","acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001209191-18-063187","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919118063187/doc4.xml","form_type":"4"}},{"id":3726204,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-12-18T21:28:07.000Z","date":"2018-12-17","kind":"sale","acquired":false,"shares":2604,"price":7.46,"value":19425.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants."}],"balance_after":32702,"source":{"system":"sec-edgar","filing":"0001209191-18-063187","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919118063187/doc4.xml","form_type":"4"}},{"id":3726203,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-12-18T21:28:07.000Z","date":"2018-12-14","kind":"exercise","acquired":true,"shares":18750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":35306,"source":{"system":"sec-edgar","filing":"0001209191-18-063187","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919118063187/doc4.xml","form_type":"4"}},{"id":3731750,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-12-13T21:40:54.000Z","date":"2018-12-11","kind":"grant","acquired":true,"shares":410000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests 25% on December 11, 2019 and then in quarterly installments over 3 years thereafter."}],"balance_after":410000,"derivative":{"exercise_price":7.96,"expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":410000},"source":{"system":"sec-edgar","filing":"0001209191-18-062461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919118062461/doc4.xml","form_type":"4"}},{"id":4106603,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-04T21:35:35.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 25% of the shares on December 13, 2018 and then in quarterly installments over 3 years thereafter."}],"balance_after":200000,"derivative":{"exercise_price":6.2,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-18-001965","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919118001965/doc4.xml","form_type":"4"}},{"id":4129906,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit","published_at":"2017-12-15T21:44:46.000Z","date":"2017-12-14","kind":"exercise","acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date."}],"balance_after":56250,"derivative":{"underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001209191-17-065970","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919117065970/doc4.xml","form_type":"4"}},{"id":4129905,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-12-15T21:44:46.000Z","date":"2017-12-13","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests as to 25% of the shares on December 13, 2018 and then in quarterly installments over 3 years thereafter."}],"balance_after":350000,"derivative":{"exercise_price":6.1,"expiration_date":"2027-12-13","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001209191-17-065970","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919117065970/doc4.xml","form_type":"4"}},{"id":4129904,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-12-15T21:44:46.000Z","date":"2017-12-14","kind":"sale","acquired":false,"shares":2194,"price":5.85,"value":12834.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock\nin connection with the settlement of the vested portion of RSUs pursuant to the terms of that certain RSU Agreement between the Reporting Person and the Issuer, as reflected in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.80 to $5.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4."}],"balance_after":16556,"source":{"system":"sec-edgar","filing":"0001209191-17-065970","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919117065970/doc4.xml","form_type":"4"}},{"id":4129903,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-12-15T21:44:46.000Z","date":"2017-12-14","kind":"exercise","acquired":true,"shares":18750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock"}],"balance_after":18750,"source":{"system":"sec-edgar","filing":"0001209191-17-065970","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919117065970/doc4.xml","form_type":"4"}},{"id":4463492,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-07T21:31:50.000Z","date":"2017-02-06","kind":"exercise","acquired":false,"shares":2185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest as follows: 25% vested on December 4, 2016 and the remainder vests in quarterly installments over 3 years thereafter."}],"balance_after":285719,"derivative":{"exercise_price":4.71,"expiration_date":"2025-12-03","underlying":"Common Stock","underlying_shares":2185},"source":{"system":"sec-edgar","filing":"0001209191-17-008356","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919117008356/doc4.xml","form_type":"4"}},{"id":4463491,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-07T21:31:50.000Z","date":"2017-02-03","kind":"exercise","acquired":false,"shares":32096,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest as follows: 25% vested on December 4, 2016 and the remainder vests in quarterly installments over 3 years thereafter."}],"balance_after":287904,"derivative":{"exercise_price":4.71,"expiration_date":"2025-12-03","underlying":"Common Stock","underlying_shares":32096},"source":{"system":"sec-edgar","filing":"0001209191-17-008356","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919117008356/doc4.xml","form_type":"4"}},{"id":4463490,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-02-07T21:31:50.000Z","date":"2017-02-06","kind":"sale","acquired":false,"shares":2185,"price":11,"value":24035.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2016."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-008356","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919117008356/doc4.xml","form_type":"4"}},{"id":4463489,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-02-07T21:31:50.000Z","date":"2017-02-06","kind":"exercise","acquired":true,"shares":2185,"price":4.71,"value":10291.35,"ownership":{"direct":true},"balance_after":2185,"source":{"system":"sec-edgar","filing":"0001209191-17-008356","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919117008356/doc4.xml","form_type":"4"}},{"id":4463488,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-02-07T21:31:50.000Z","date":"2017-02-03","kind":"sale","acquired":false,"shares":32096,"price":11.02,"value":353697.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 - $11.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-008356","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919117008356/doc4.xml","form_type":"4"}},{"id":4463487,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-02-07T21:31:50.000Z","date":"2017-02-03","kind":"exercise","acquired":true,"shares":32096,"price":4.71,"value":151172.16,"ownership":{"direct":true},"balance_after":32096,"source":{"system":"sec-edgar","filing":"0001209191-17-008356","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919117008356/doc4.xml","form_type":"4"}},{"id":4518356,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-16T22:06:05.000Z","date":"2016-12-14","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price is the closing price of the Issuer's common stock on December 14, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option shall vest as follows: 25% on December 14, 2017 and then in quarterly installments over 3 years thereafter."}],"balance_after":150000,"derivative":{"exercise_price":13.45,"expiration_date":"2026-12-13","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-16-155690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919116155690/doc4.xml","form_type":"4"}},{"id":4518355,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":40801,"kind":"person","name":"Luthringer Remy","position":1,"cik":"0001610384","reported_name":"Luthringer Remy","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Unit","published_at":"2016-12-16T22:06:05.000Z","date":"2016-12-14","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents shares issuable upon the vesting of restricted stock units (\"RSUs\") awarded to the Reporting Person on December 14, 2016. The\nRSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long\nas there has been no break in the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents shares issuable upon the vesting of restricted stock units (\"RSUs\") awarded to the Reporting Person on December 14, 2016. The\nRSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long\nas there has been no break in the Reporting Person's continuous service through such date."}],"balance_after":75000,"derivative":{"underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-16-155690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598646/000120919116155690/doc4.xml","form_type":"4"}}]}